StocksFin Logo
MYGN logo
$MYGN

Myriad Genetics, Inc.

MYGN country of incorporation
|
https://myriad.com
|
Mr. R. Bryan Riggsbee
|
2,400 employees
NASDAQ | Healthcare | Diagnostics & Research
MYGN reported its Q322 earnings on November 2, 2022 (98 weeks ago).
$156.4M -6.5% vs. Q321 Revenues Q322
67.77% -5.1% vs. Q321 Gross Profit Margin
-22.44% ! -252.6% vs. Q321 Net Profit Margin
-19.5M ! 53.9% vs. Q321 Free Cash Flow Q322
$-0.43 ! -238.7% vs. Q321 EPS Q322
Company Card Q322
As reported on November 2, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Company Card Q322
As reported on November 2, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
156.4M
-12.8%
50.4M
-35.1M
-148.9%
$-0.43
Q22022
179.3M
+8.7%
49.7M
-14.1M
+31.2%
$-0.18
Q12022
164.9M
48M
-20.5M
$-0.26
FY2021
690.6M
 197.6M
-27.2M
$-0.35
Q42021
160.8M
-3.9%
45.8M
-7.6M
-481.6%
$-0.1
Q42021
154.6M
+10.7%
47.1M
-44.2M
+50%
$-0.59
Q32021
167.3M
-13.2%
47.8M
24.6M
-161.8%
$0.31
Q32021
145.2M
44.2M
-15.2M
$-0.2
Q22021
189.4M
53.7M
-4.7M
$-0.06
Q12021
173.1M
50.3M
-39.5M
$-0.52
FY2020
638.6M
 186.1M
-199.5M
$-2.69
FY2019
851.1M
 201M
4.6M
$0.06
FY2018
772.6M
 177.2M
131.1M
$1.89
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
1.21B
 295.4M
110.7M
137.3M
916.6M
Q22022
1.21B
 262.8M
105.2M
100.7M
947.4M
Q12022
1.26B
 305.3M
165.2M
89.9M
950.1M
FY2021
1.32B
 352.9M
258.4M
105.3M
967.8M
FY2020
1.4B
 486.4M
163.7M
224.4M
918.2M
FY2019
1.56B
 473.8M
93.2M
233.5M
1.09B
FY2018
1.17B
 209.2M
110.9M
9.3M
964.9M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-1.8M
 11.4M
-3.6M
-17.7M
-19.5M
+65.8%
Q22022
-50.3M
 -12M
2.5M
-6.7M
-57M
-8%
Q12022
-46.5M
 -41.3M
-4.8M
-6.3M
-52.8M
FY2021
18.2M
 274.4M
-150.6M
-18M
200k
FY2020
60.7M
 19.3M
-10M
-10.2M
50.5M
FY2019
83.7M
 -286.4M
182.3M
-8.6M
75.1M
FY2018
115.9M
 -11.6M
-95M
-8.4M
107.5M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees